<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK63582" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK63582/" /><meta name="ncbi_pagename" content="Short-Chain Acyl-CoA Dehydrogenase Deficiency - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Short-Chain Acyl-CoA Dehydrogenase Deficiency - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Short-Chain Acyl-CoA Dehydrogenase Deficiency" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/08/09" /><meta name="citation_author" content="Lynne Wolfe" /><meta name="citation_author" content="Reena Jethva" /><meta name="citation_author" content="Devin Oglesbee" /><meta name="citation_author" content="Jerry Vockley" /><meta name="citation_pmid" content="21938826" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK63582/" /><meta name="citation_keywords" content="SCADD" /><meta name="citation_keywords" content="SCAD Deficiency" /><meta name="citation_keywords" content="SCAD Deficiency" /><meta name="citation_keywords" content="SCADD" /><meta name="citation_keywords" content="Short-chain specific acyl-CoA dehydrogenase, mitochondrial" /><meta name="citation_keywords" content="ACADS" /><meta name="citation_keywords" content="Short-Chain Acyl-CoA Dehydrogenase Deficiency" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Short-Chain Acyl-CoA Dehydrogenase Deficiency" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Lynne Wolfe" /><meta name="DC.Contributor" content="Reena Jethva" /><meta name="DC.Contributor" content="Devin Oglesbee" /><meta name="DC.Contributor" content="Jerry Vockley" /><meta name="DC.Date" content="2018/08/09" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK63582/" /><meta name="description" content="Most infants with short-chain acyl-CoA dehydrogenase deficiency (SCADD) identified through newborn screening programs have remained well, and asymptomatic relatives who meet diagnostic criteria are reported. Thus, SCADD is now viewed as a biochemical phenotype rather than a disease. A broad range of clinical findings was originally reported in those with confirmed SCADD, including severe dysmorphic facial features, feeding difficulties / failure to thrive, metabolic acidosis, ketotic hypoglycemia, lethargy, developmental delay, seizures, hypotonia, dystonia, and myopathy. However, individuals with no symptoms were also reported. In a large series of affected individuals detected on metabolic evaluation for developmental delay, 20% had failure to thrive, feeding difficulties, and hypotonia; 22% had seizures; and 30% had hypotonia without seizures. In contrast, the majority of infants with SCADD have been detected by expanded newborn screening, and the great majority of these infants remain asymptomatic. As with other fatty acid oxidation deficiencies, characteristic biochemical findings of SCADD may be absent except during times of physiologic stress such as fasting and illness. A diagnosis of SCADD based on clinical findings should not preclude additional testing to look for other causes." /><meta name="og:title" content="Short-Chain Acyl-CoA Dehydrogenase Deficiency" /><meta name="og:type" content="book" /><meta name="og:description" content="Most infants with short-chain acyl-CoA dehydrogenase deficiency (SCADD) identified through newborn screening programs have remained well, and asymptomatic relatives who meet diagnostic criteria are reported. Thus, SCADD is now viewed as a biochemical phenotype rather than a disease. A broad range of clinical findings was originally reported in those with confirmed SCADD, including severe dysmorphic facial features, feeding difficulties / failure to thrive, metabolic acidosis, ketotic hypoglycemia, lethargy, developmental delay, seizures, hypotonia, dystonia, and myopathy. However, individuals with no symptoms were also reported. In a large series of affected individuals detected on metabolic evaluation for developmental delay, 20% had failure to thrive, feeding difficulties, and hypotonia; 22% had seizures; and 30% had hypotonia without seizures. In contrast, the majority of infants with SCADD have been detected by expanded newborn screening, and the great majority of these infants remain asymptomatic. As with other fatty acid oxidation deficiencies, characteristic biochemical findings of SCADD may be absent except during times of physiologic stress such as fasting and illness. A diagnosis of SCADD based on clinical findings should not preclude additional testing to look for other causes." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK63582/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/scad/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK63582/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8C88C0DFC886D10000000003530185.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK63582_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK63582_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/spr-def/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/sgs/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK63582_"><span class="title" itemprop="name">Short-Chain Acyl-CoA Dehydrogenase Deficiency</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: SCADD, SCAD Deficiency</div><p class="contrib-group"><span itemprop="author">Lynne Wolfe</span>, MS, CRNP, BC, <span itemprop="author">Reena Jethva</span>, MD, <span itemprop="author">Devin Oglesbee</span>, PhD, and <span itemprop="author">Jerry Vockley</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK63582_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK63582_ai__"><div class="contrib half_rhythm"><span itemprop="author">Lynne Wolfe</span>, MS, CRNP, BC<div class="affiliation small">National Human Genome Research Institute<br />National Institutes of Health<br />Bethesda, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin@eflow.ennyl" class="oemail">vog.hin@eflow.ennyl</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Reena Jethva</span>, MD<div class="affiliation small">St Christopher's Hospital for Children<br />Philadelphia, Pennsylvania<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.demlexerd@avhtej.aneer" class="oemail">ude.demlexerd@avhtej.aneer</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Devin Oglesbee</span>, PhD<div class="affiliation small">Mayo Clinic<br />Rochester, Minnesota<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.oyam@nived.eebselgo" class="oemail">ude.oyam@nived.eebselgo</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Jerry Vockley</span>, MD, PhD<div class="affiliation small">University of Pittsburgh<br />Pittsburgh, Pennsylvania<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.phc@yelkcov.drareg" class="oemail">ude.phc@yelkcov.drareg</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">September 22, 2011</span>; Last Update: <span itemprop="dateModified">August 9, 2018</span>.</p><p><em>Estimated reading time: 19 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="scad.Summary" itemprop="description"><h2 id="_scad_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Most infants with short-chain acyl-CoA dehydrogenase deficiency (SCADD) identified through <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> programs have remained well, and asymptomatic relatives who meet diagnostic criteria are reported. Thus, SCADD is now viewed as a biochemical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> rather than a disease. A broad range of clinical findings was originally reported in those with confirmed SCADD, including severe <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> facial features, feeding difficulties / failure to thrive, metabolic acidosis, ketotic hypoglycemia, lethargy, developmental delay, seizures, hypotonia, dystonia, and myopathy. However, individuals with no symptoms were also reported. In a large series of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals detected on metabolic evaluation for developmental delay, 20% had failure to thrive, feeding difficulties, and hypotonia; 22% had seizures; and 30% had hypotonia without seizures. In contrast, the majority of infants with SCADD have been detected by expanded newborn screening, and the great majority of these infants remain asymptomatic. As with other fatty acid oxidation deficiencies, characteristic biochemical findings of SCADD may be absent except during times of physiologic stress such as fasting and illness. A diagnosis of SCADD based on clinical findings should not preclude additional testing to look for other causes.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>SCADD has been defined as the presence of:</p><ul><li class="half_rhythm"><div class="half_rhythm">Increased butyrylcarnitine (C4) concentrations in plasma and/or increased ethylmalonic acid (EMA) concentrations in urine under non-stressed conditions (on at least two occasions);</div><div class="half_rhythm">AND</div></li><li class="half_rhythm"><div class="half_rhythm">Biallelic <i>ACADS</i> pathogenic variants.</div></li></ul></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> As most individuals with SCADD are asymptomatic, there is no need for treatment. There are no generally accepted recommendations for dietary manipulation or use of carnitine and/or riboflavin supplementation.</p><p><i>Prevention of primary manifestations:</i> No preventive measures are necessary.</p><p><i>Surveillance:</i> Longitudinal follow up of persons with SCADD on a research basis may be helpful in order to more clearly define the natural history over the life span, including annual visits to a metabolic clinic to assess growth and development as well as nutritional status (protein and iron stores, concentration of RBC or plasma essential fatty acids, and plasma carnitine concentration).</p></div><div><h4 class="inline">Genetic counseling.</h4><p>SCADD is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an individual with SCADD has a 25% chance of inheriting <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>ACADS</i> pathogenic or susceptibility variants and possibly developing clinical findings associated with SCADD, a 50% chance of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>ACADS</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, and a 25% chance of not being a carrier. If the pathogenic variants in the family have been identified, <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a> for at-risk family members is possible, and prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible but not necessary and not recommended.</p></div></div><div id="scad.Diagnosis"><h2 id="_scad_Diagnosis_">Diagnosis</h2><p>Short-chain acyl-CoA dehydrogenase deficiency (SCADD) has been defined as the presence of:</p><ul><li class="half_rhythm"><div class="half_rhythm">Increased butyrylcarnitine (C4) concentrations in plasma and/or increased ethylmalonic acid (EMA) concentrations in urine under non-stressed conditions (on at least two occasions)</div><div class="half_rhythm">AND</div></li><li class="half_rhythm"><div class="half_rhythm">Biallelic <i>ACADS</i> pathogenic variants.</div></li></ul><p>Most infants with SCADD identified through <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> programs have remained well, and asymptomatic relatives who meet diagnostic criteria are reported. Thus, SCADD is now viewed as a biochemical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> rather than a disease. Some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have been identified through metabolic evaluation for developmental delay. As with other fatty acid oxidation deficiencies, characteristic biochemical findings of SCADD may be absent except during times of physiologic stress such as fasting and illness.</p><div id="scad.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Short-chain acyl CoA dehydrogenase deficiency (SCADD) <b>should be suspected</b> in infants with a positive <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> result and in symptomatic individuals with supportive clinical and laboratory findings.</p><div id="scad.Positive_Newborn_Screening_NBS_Resu"><h4>Positive Newborn Screening (NBS) Result</h4><p>NBS for SCADD is primarily based on acylcarnitine analysis by tandem mass spectrometry to detect elevated blood C4 (butyrylcarnitine).</p><p>Note: (1) Normal ranges for isolated C4 vary from state to state, necessitating confirmatory testing consistent with the American College of Medical Genetics (ACMG) <a href="http://www.acmg.net/PDFLibrary/C4.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ACT Sheet</a>. (2) Isobutyryl-CoA dehydrogenase deficiency (IBDD) that leads to elevation of isobutyrylcarnitine, a C4 species also detectable by NBS, must be distinguished from SCADD by additional laboratory testing.</p><p>C4 values above the cutoff reported by the screening laboratory are considered positive and require additional biochemical testing and in most cases <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> to establish the diagnosis (see <a href="#scad.Establishing_the_Diagnosis">Establishing the Diagnosis</a>).</p></div><div id="scad.Symptomatic_Individuals"><h4>Symptomatic Individuals</h4><p>For symptomatic individuals who were not identified on NBS, the following nonspecific clinical features and preliminary laboratory findings support a diagnosis of SCADD:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Clinical findings.</b> Hypotonia, dystonia, seizures, metabolic acidosis associated with illness, and/or hypoglycemia [<a class="bk_pop" href="#scad.REF.corydon.2001.18">Corydon et al 2001</a>]</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Preliminary laboratory findings.</b> Increased C4 concentrations in plasma and/or increased ethylmalonic acid (EMA) concentrations in urine on biochemical evaluation</div><div class="half_rhythm">Note: Because elevations of these metabolites individually are not entirely specific to SCADD, follow-up testing to establish or rule out the diagnosis of SCADD is required (see <a href="#scad.Establishing_the_Diagnosis">Establishing the Diagnosis</a>).</div></li></ul></div></div><div id="scad.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of SCADD <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with typical findings on biochemical testing and confirmed by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of <i>ACADS</i> with the identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants (see <a class="figpopup" href="/books/NBK63582/table/scad.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figscadTmoleculargenetictestingusedin" rid-ob="figobscadTmoleculargenetictestingusedin">Table 1</a>).</p><p>Note: Two common variants may lead to the biochemical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, but are not clinically relevant (see <a class="figpopup" href="/books/NBK63582/table/scad.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figscadTmoleculargenetictestingusedin" rid-ob="figobscadTmoleculargenetictestingusedin">Table 1</a> footnote 4).</p><p><b>Biochemical testing</b></p><ul><li class="half_rhythm"><div><b>Acylcarnitine profile</b> testing is used to confirm C4 elevations.</div></li><li class="half_rhythm"><div><b>Urine acylglycines.</b> A random urine sample can be used to differentiate butyrylglycine and isobutyrylglycine and to detect elevated ethylmalonic acid (EMA) as part of either confirmatory testing after a positive newborn screen or diagnostic testing in older children and adults being evaluated for SCADD.</div></li><li class="half_rhythm"><div><b>Urine organic acids.</b> A random urine sample can be collected to detect EMA and dicarboxylic acids, which may be helpful in confirmation of an abnormal newborn screen or during acute illnesses. Urine organic acid screening in symptomatic older children and adults may reveal elevated EMA [<a class="bk_pop" href="#scad.REF.pedersen.2008.43">Pedersen et al 2008</a>].</div></li></ul><p>Molecular genetic testing approaches, which depend on the clinical findings, can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (typically <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>).</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Children with the distinctive laboratory findings of SCADD described in <a href="#scad.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#scad.Option_1">Option 1</a>), whereas symptomatic individuals with nonspecific supportive clinical and laboratory findings (i.e., who had not undergone NBS or had normal NBS results) in whom the diagnosis of SCADD has not been considered are more likely to be diagnosed using comprehensive genomic testing (see <a href="#scad.Option_2">Option 2</a>).</p><div id="scad.Option_1"><h4>Option 1</h4><p>When NBS results and other laboratory findings suggest the diagnosis of SCADD, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first. If clinically necessary and only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> could be considered; however, to date no large deletions or complex rearrangements involving <i>ACADS</i> have been reported for SCADD.</div><div class="half_rhythm"><b>Note:</b> Two common <i>ACADS</i> variants, <a class="figpopup" href="/books/NBK63582/table/scad.T.acads_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figscadTacadsvariantsdiscussedinthis" rid-ob="figobscadTacadsvariantsdiscussedinthis">c.511C&#x0003e;T</a> and <a class="figpopup" href="/books/NBK63582/table/scad.T.acads_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figscadTacadsvariantsdiscussedinthis" rid-ob="figobscadTacadsvariantsdiscussedinthis">c.625G&#x0003e;A</a>, result in the SCADD biochemical abnormality when <i>in trans</i> with a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Newborns <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the <a class="figpopup" href="/books/NBK63582/table/scad.T.acads_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figscadTacadsvariantsdiscussedinthis" rid-ob="figobscadTacadsvariantsdiscussedinthis">c.625G&#x0003e;A</a> variant have laboratory test values that overlap with those of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> (i.e., with 2 pathogenic variants) newborns. These variants are not associated with clinical manifestations of SCADD.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>ACADS</i> and other genes of interest (see <a href="#scad.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul></div><div id="scad.Option_2"><h4>Option 2</h4><p>When the diagnosis of SCADD has not been considered, <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a></b>
<b>testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible. Exome array (when clinically available) may be considered if <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic; however, to date no large deletions or complex rearrangements involving <i>ACADS</i> have been reported for SCADD.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="scad.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in SCADD</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK63582/table/scad.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__scad.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_scad.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_scad.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_scad.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_scad.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>ACADS</i></td><td headers="hd_h_scad.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_scad.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~100%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_scad.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_scad.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="scad.TF.1.1"><p class="no_margin">See <a href="/books/n/gene.scad/">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="scad.TF.1.2"><p class="no_margin">See <a href="#scad.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="scad.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="scad.TF.1.4"><p class="no_margin">In individuals with biochemical findings consistent with the diagnosis of SCADD [<a class="bk_pop" href="#scad.REF.van_maldegem.2006.943">van Maldegem et al 2006</a>, <a class="bk_pop" href="#scad.REF.pedersen.2008.43">Pedersen et al 2008</a>, <a class="bk_pop" href="#scad.REF.gallant.2012.55">Gallant et al 2012</a>]. Most infants with newborn screen results consistent with SCADD are either <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on both <i>ACADS</i> alleles or <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> for a pathogenic variant on one <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> and a <a class="figpopup" href="/books/NBK63582/table/scad.T.acads_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figscadTacadsvariantsdiscussedinthis" rid-ob="figobscadTacadsvariantsdiscussedinthis">c.511C&#x0003e;T</a> or <a class="figpopup" href="/books/NBK63582/table/scad.T.acads_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figscadTacadsvariantsdiscussedinthis" rid-ob="figobscadTacadsvariantsdiscussedinthis">c.625G&#x0003e;A</a> variant on the other allele [<a class="bk_pop" href="#scad.REF.lindner.2010.521">Lindner et al 2010</a>]; however, newborns homozygous for the <a class="figpopup" href="/books/NBK63582/table/scad.T.acads_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figscadTacadsvariantsdiscussedinthis" rid-ob="figobscadTacadsvariantsdiscussedinthis">c.625G&#x0003e;A</a> variant have laboratory test values that overlap with those of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> (i.e., with 2 pathogenic variants) newborns.</p></div></dd><dt>5. </dt><dd><div id="scad.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="scad.TF.1.6"><p class="no_margin">Most studies have performed only <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>; therefore, no data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available. Given the proposed mechanism of disease, such events are likely to be rare.</p></div></dd></dl></div></div></div></div></div></div><div id="scad.Clinical_Characteristics"><h2 id="_scad_Clinical_Characteristics_">Clinical Characteristics</h2><div id="scad.Clinical_Description"><h3>Clinical Description</h3><p>A broad range of clinical findings was originally reported in those with confirmed short-chain acyl-coA dehydrogenase deficiency (SCADD), including severe <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> facial features, feeding difficulties / failure to thrive, metabolic acidosis, ketotic hypoglycemia, lethargy, developmental delay, seizures, hypotonia, dystonia, and myopathy. However, individuals with no symptoms were also reported.</p><p>SCADD was first reported in two neonates who had increased urinary ethylmalonic acid (EMA) excretion; the diagnosis was confirmed enzymatically in skin fibroblasts [<a class="bk_pop" href="#scad.REF.amendt.1987.1303">Amendt et al 1987</a>]. One of these infants died of overwhelming neonatal acidosis as would be typical of an organic acidemia. However, over the last 20 years more experience with the natural history of SCADD in persons with the biochemical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> has identified a much broader phenotypic spectrum than originally anticipated.</p><p>Since most infants with SCADD identified through <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> programs have been well at the time of diagnosis, the reported relationship of clinical manifestations to the deficiency of SCAD has come into question [<a class="bk_pop" href="#scad.REF.waisbren.2008.39">Waisbren et al 2008</a>]. Most recent publications based on newborn screening identification have suggested that SCADD causes only a biochemical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> that is not clinically relevant, although occasional publications demonstrating some cellular phenotype related to SCADD still appear in the literature [<a class="bk_pop" href="#scad.REF.van_maldegem.2006.943">van Maldegem et al 2006</a>, <a class="bk_pop" href="#scad.REF.jethva.2008.195">Jethva et al 2008</a>, <a class="bk_pop" href="#scad.REF.van_maldegem.2010c.507">van Maldegem et al 2010c</a>, <a class="bk_pop" href="#scad.REF.gallant.2012.55">Gallant et al 2012</a>, <a class="bk_pop" href="#scad.REF.tonin.2016.114">Tonin et al 2016</a>, <a class="bk_pop" href="#scad.REF.nochi.2017.641">Nochi et al 2017</a>].</p><p>The most convincing study on the clinical relevance of SCADD was reported in 76 babies out of 2,632,058 screened in California over a five-year period [<a class="bk_pop" href="#scad.REF.gallant.2012.55">Gallant et al 2012</a>]. Clinical follow up was available on 31 infants, none of whom had any findings suggestive of a metabolic disorder. Seven of these babies with available molecular information were <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> or <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> for two pathogenic variants, eight had one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and either the <a class="figpopup" href="/books/NBK63582/table/scad.T.acads_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figscadTacadsvariantsdiscussedinthis" rid-ob="figobscadTacadsvariantsdiscussedinthis">c.511C&#x0003e;T</a> or <a class="figpopup" href="/books/NBK63582/table/scad.T.acads_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figscadTacadsvariantsdiscussedinthis" rid-ob="figobscadTacadsvariantsdiscussedinthis">c.625G&#x0003e;A</a> variant (see <a class="figpopup" href="/books/NBK63582/table/scad.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figscadTmoleculargenetictestingusedin" rid-ob="figobscadTmoleculargenetictestingusedin">Table 1</a>), and seven had two alleles that were either c.511C&#x0003e;T or c.625G&#x0003e;A. In an additional study of 12 individuals with biochemical findings suggestive of SCADD, ten were identified before age three weeks; all were either asymptomatic or reported to have mild hypotonia [<a class="bk_pop" href="#scad.REF.tonin.2016.114">Tonin et al 2016</a>]. Two older individuals with variable symptoms were shown only to have the common benign polymorphisms.</p><p>All older reports on SCADD identified symptomatic individuals retrospectively; many of such reports did not differentiate between true deficiency and the presence of the <a class="figpopup" href="/books/NBK63582/table/scad.T.acads_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figscadTacadsvariantsdiscussedinthis" rid-ob="figobscadTacadsvariantsdiscussedinthis">c.511C&#x0003e;T</a> or <a class="figpopup" href="/books/NBK63582/table/scad.T.acads_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figscadTacadsvariantsdiscussedinthis" rid-ob="figobscadTacadsvariantsdiscussedinthis">c.625G&#x0003e;A</a> variant. <a class="bk_pop" href="#scad.REF.pedersen.2008.43">Pedersen et al [2008]</a> summarized the findings in 114 individuals, mostly children undergoing metabolic evaluation for developmental delay. Among the 114 with developmental delay, three subgroups were identified:</p><ul><li class="half_rhythm"><div>23 (20%) with failure to thrive, feeding difficulties, and hypotonia</div></li><li class="half_rhythm"><div>25 (22%) with seizures</div></li><li class="half_rhythm"><div>34 (30%) with hypotonia without seizures</div></li></ul><p>Four individuals were asymptomatic, identified either through family studies or <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> programs.</p><p>In a retrospective study from the Netherlands, <a class="bk_pop" href="#scad.REF.van_maldegem.2006.943">van Maldegem et al [2006]</a> identified 31 individuals who met the biochemical and molecular diagnostic criteria for SCADD and also had sufficient information on health and development. The most frequently reported clinical findings were developmental delay (16; designated as "non-severe" in 15), epilepsy (11; non-severe in all), behavioral disorder (8; non-severe in 5), and history of hypoglycemia (6; non-severe in 5). Follow up ranged from one to 18 years: two had progressive clinical deterioration, 12 had no change in clinical findings, eight improved, and nine had complete recovery. In addition, three parents and six sibs were found to have <i>ACADS</i> genotypes identical to the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>; eight of the nine had increased levels of C4 and/or EMA, and one of the six sibs had transient feeding difficulties in the first year.</p><p>In a study of ten <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals of <a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> ancestry, eight had developmental delay and four had muscle biopsy-proven multiminicore myopathy [<a class="bk_pop" href="#scad.REF.tein.2008.179">Tein et al 2008</a>]. It has been noted that persons with SCADD with a myopathy reported as multiminicore disease had not undergone a full evaluation and may have had another unrelated cause for their muscle disease such as pathogenic variants in <i>RYR1</i> or <i>SELENON</i> (<i>SEPN1</i>) [<a class="bk_pop" href="#scad.REF.van_maldegem.2010c.507">van Maldegem et al 2010c</a>].</p><p>As in other fatty acid oxidation disorders, characteristic biochemical findings of SCADD may be absent in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals except during times of physiologic stress including fasting and illness [<a class="bk_pop" href="#scad.REF.bok.2003.1152">Bok et al 2003</a>, <a class="bk_pop" href="#scad.REF.pedersen.2008.43">Pedersen et al 2008</a>]. In addition, manifestations early in life that could be attributed to SCADD appear to resolve completely during long-term follow up for most individuals diagnosed with SCAD.</p><p>Individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> common variants (<a class="figpopup" href="/books/NBK63582/table/scad.T.acads_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figscadTacadsvariantsdiscussedinthis" rid-ob="figobscadTacadsvariantsdiscussedinthis">c.511C&#x0003e;T</a> and <a class="figpopup" href="/books/NBK63582/table/scad.T.acads_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figscadTacadsvariantsdiscussedinthis" rid-ob="figobscadTacadsvariantsdiscussedinthis">c.625G&#x0003e;A</a>) are so prevalent in the general population that this finding cannot represent a significant risk for clinical disease (see <a href="#scad.Molecular_Genetics">Molecular Genetics</a>). Individuals with an <a class="def" href="/books/n/gene/glossary/def-item/inactivating/">inactivating</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on one <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> and one of these variants on the other have enzymatic dysfunction that falls between the those with biallelic common variants and those with biallelic inactivating variants. However, California <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> data showed that these babies remained asymptomatic [<a class="bk_pop" href="#scad.REF.gallant.2012.55">Gallant et al 2012</a>].</p><p><b>Pregnancy-related issues.</b> Acute fatty liver of pregnancy (AFLP), preeclampsia, and/or HELLP syndrome in mothers of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> fetuses have been described, but causation has not been established [<a class="bk_pop" href="#scad.REF.matern.2001.585">Matern et al 2001</a>, <a class="bk_pop" href="#scad.REF.bok.2003.1152">Bok et al 2003</a>, <a class="bk_pop" href="#scad.REF.van_maldegem.2010c.507">van Maldegem et al 2010c</a>].</p></div><div id="scad.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No consistent clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a> correlations have been observed. However, data have suggested a correlation between urinary levels of biomarkers (ethylmalonic acid and methylsuccinic acid) and presence of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants versus one pathogenic and either the <a class="figpopup" href="/books/NBK63582/table/scad.T.acads_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figscadTacadsvariantsdiscussedinthis" rid-ob="figobscadTacadsvariantsdiscussedinthis">c.511C&#x0003e;T</a> or <a class="figpopup" href="/books/NBK63582/table/scad.T.acads_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figscadTacadsvariantsdiscussedinthis" rid-ob="figobscadTacadsvariantsdiscussedinthis">c.625G&#x0003e;A</a> variant on each <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> [<a class="bk_pop" href="#scad.REF.gallant.2012.55">Gallant et al 2012</a>].</p></div><div id="scad.Prevalence"><h3>Prevalence</h3><p>Using fairly strict biochemical and molecular criteria, a birth prevalence of at least 1:50,000 has been estimated in the Netherlands [<a class="bk_pop" href="#scad.REF.van_maldegem.2006.943">van Maldegem et al 2006</a>]. A prevalence of 1:34,632 or approximately 1:35,000 was calculated from California data for the incidence in the US [<a class="bk_pop" href="#scad.REF.gallant.2012.55">Gallant et al 2012</a>].</p><p>SCADD appears to be pan ethnic.</p></div></div><div id="scad.Genetically_Related_Allelic_Disorde"><h2 id="_scad_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>ACADS.</i></p></div><div id="scad.Differential_Diagnosis"><h2 id="_scad_Differential_Diagnosis_">Differential Diagnosis</h2><p>Other disorders to consider in the differential diagnosis:</p><ul><li class="half_rhythm"><div><b>Isobutyryl-CoA dehydrogenase deficiency (IBDD)</b> (OMIM <a href="https://omim.org/entry/611283" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">611283</a>). IBDD, also detectable by NBS, leads to elevation of isobutyrylcarnitine, a C4 species indistinguishable from butyrylcarntine without additional separation techniques. IBDD presents with relatively mild and nonspecific hypotonia and is most often asymptomatic at birth. Thus, it is clinically identical to short-chain acyl-CoA dehydrogenase deficiency (SCADD) in newborns. IBDD is caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> variants in <i>ACAD8</i>.</div></li><li class="half_rhythm"><div><b>Glutaric acidemia type II (GAII),</b> also known as multiple acyl-CoA dehydrogenase deficiency (MADD) (OMIM <a href="http://www.omim.org/entry/231680" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">231680</a>), can present with ethylmalonic acid in urine and C4 in blood but has distinguishing biochemical characteristics related to secondary deficiencies of all of the fatty acyl-CoA dehydrogenases. This disorder is caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> variants in one of three genes: <i>ETFA</i>, <i>ETFB</i>, or <i>ETFDH</i>.</div></li><li class="half_rhythm"><div><b>Ethylmalonic encephalopathy</b> (OMIM <a href="http://omim.org/entry/602473" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">602473</a>) presents with ethylmalonic acid in urine at much higher levels than in SCADD. C4 may be higher, but as in GAII, other metabolites may be elevated. The clinical characteristics of orthostatic acrocyanosis, petechiae, and severe neurologic symptoms distinguish it from SCADD. This disorder is caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> variants in <i>ETHE1</i>.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/mt-overview/"><b>Mitochondrial respiratory chain defects</b></a> are a group of pleotropic disorders that may show mild elevation of ethylmalonic acid in urine and C4 in blood. In practice, these disorders may be the most difficult to distinguish from SCADD, and in minimally symptomatic individuals without lactic acidemia, molecular testing may be necessary to establish a diagnosis.</div></li><li class="half_rhythm"><div><b>Jamaican vomiting sickness.</b> This condition, characterized by acute hypoglycemia, is caused by eating the unripe ackee fruit, which contains an inhibitor of the acyl-CoA dehydrogenases. The effect is most pronounced for long-chain and medium-chain enzymes, and thus, while small amounts of short-chain organic acids may be seen in urine, the biochemical diagnosis is straightforward.</div></li></ul></div><div id="scad.Management"><h2 id="_scad_Management_">Management</h2><p>To establish the extent of disease and needs in an individual diagnosed with short-chain acyl-coA dehydrogenase deficiency (SCADD), the evaluations summarized in this section (if not performed as part of the evaluation that led to the diagnosis) are recommended.</p><div id="scad.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>Once a molecular diagnosis of SCAD deficiency is made, there is no need for additional clinical evaluation or further follow up.</p></div><div id="scad.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Since SCADD is now viewed as a biochemical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> rather than a disease, there is no need for treatment.</p><p>Given the paucity of research, especially long-term follow-up studies, enrollment in a long-term follow-up study with a biochemical geneticist can be offered.</p></div><div id="scad.Prevention_of_Primary_Manifestation"><h3>Prevention of Primary Manifestations</h3><p>Preventive measures if necessary include avoidance of fasting longer than 12 hours (during childhood) and an age-appropriate heart-healthy diet. For infants and toddlers, age-appropriate shorter limits on fasting periods would be required. No dietary fat restriction or specific supplements are recommended in SCADD [<a class="bk_pop" href="#scad.REF.bennett.2010.533">Bennett 2010</a>, <a class="bk_pop" href="#scad.REF.van_maldegem.2010a.121">van Maldegem et al 2010a</a>].</p></div><div id="scad.Surveillance"><h3>Surveillance</h3><p>Longitudinal follow up of persons with SCADD on a research basis, including annual visits to a metabolic clinic to assess growth and development as well as nutritional status (protein and iron stores, concentration of RBC or plasma essential fatty acids, and plasma carnitine concentration), may be helpful in order to more clearly define the natural history over the life span.</p></div><div id="scad.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#scad.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="scad.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="scad.Genetic_Counseling"><h2 id="_scad_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="scad.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Short-chain acyl-CoA dehydrogenase deficiency (SCADD) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="scad.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of a child with SCADD are obligate heterozygotes (i.e., carriers of one <i>ACADS</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing clinical findings related to SCADD.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an individual with SCADD has a 25% chance of inheriting <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>ACADS</i> pathogenic variants and possibly developing biochemical findings associated with SCADD, a 50% chance of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>ACADS</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, and a 25% chance of not being a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing clinical findings related to SCADD.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with SCADD are obligate heterozygotes (carriers) for an <i>ACADS</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>ACADS</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="scad.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk family members is possible if the <i>ACADS</i> pathogenic variants in the family have been identified.</p></div><div id="scad.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who have SCADD, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="scad.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>ACADS</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are both possible but are unnecessary and not recommended.</p></div></div><div id="scad.Resources"><h2 id="_scad_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=shortchainacylcoenzymeadehydrogenasedeficiency" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Short-chain acyl-coenzyme A dehydrogenase deficiency</a></div></li><li class="half_rhythm"><div><b>Save Babies Through Screening Foundation, Inc.</b></div><div>P. O. Box 42197</div><div>Cincinnati OH 45242</div><div><b>Phone:</b> 888-454-3383</div><div><b>Email:</b> email@savebabies.org</div><div><a href="http://www.savebabies.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.savebabies.org</a></div></li><li class="half_rhythm"><div><b>FOD Family Support Group (Fatty Oxidation Disorder)</b></div><div>PO Box 54</div><div>Okemos MI 48805-0054</div><div><b>Phone:</b> 517-381-1940</div><div><b>Fax:</b> 866-290-5206 (toll-free)</div><div><b>Email:</b> deb@fodsupport.org; fodgroup@gmail.com</div><div><a href="http://www.fodsupport.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.fodsupport.org</a></div></li><li class="half_rhythm"><div><b>Metabolic Support UK</b></div><div>5 Hilliards Court, Sandpiper Way</div><div>Chester Business Park</div><div>Chester CH4 9QP </div><div>United Kingdom</div><div><b>Phone:</b> 0845 241 2173</div><div><b>Email:</b> contact@metabolicsupportuk.org</div><div><a href="https://www.metabolicsupportuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.metabolicsupportuk.org</a></div></li><li class="half_rhythm"><div><b>United Mitochondrial Disease Foundation (UMDF)</b></div><div>8085 Saltsburg Road</div><div>Suite 201</div><div>Pittsburg PA 15239</div><div><b>Phone:</b> 888-317-8633 (toll-free); 412-793-8077</div><div><b>Fax:</b> 412-793-6477</div><div><b>Email:</b> info@umdf.org</div><div><a href="http://www.umdf.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.umdf.org</a></div></li></ul></div><div id="scad.Molecular_Genetics"><h2 id="_scad_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="scad.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Short-Chain Acyl-CoA Dehydrogenase Deficiency: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK63582/table/scad.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__scad.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_scad.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_scad.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_scad.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_scad.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_scad.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_scad.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_scad.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/35" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ACADS</i></a></td><td headers="hd_b_scad.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=35" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">12q24<wbr style="display:inline-block"></wbr>​.31</a></td><td headers="hd_b_scad.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P16219" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Short-chain specific acyl-CoA dehydrogenase, mitochondrial</a></td><td headers="hd_b_scad.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/ACADS" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ACADS database</a></td><td headers="hd_b_scad.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ACADS" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ACADS</a></td><td headers="hd_b_scad.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ACADS[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ACADS</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="scad.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="scad.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Short-Chain Acyl-CoA Dehydrogenase Deficiency (<a href="/omim/201470,606885" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK63582/table/scad.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__scad.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/201470" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">201470</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF; ACADSD</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606885" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606885</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ACYL-CoA DEHYDROGENASE, SHORT-CHAIN; ACADS</td></tr></tbody></table></div></div><div id="scad.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p>Possible pathogenic explanations for the observation that most individuals with short-chain acyl-CoA dehydrogenase (SCAD) deficiency do not present with the classic picture of metabolic acidosis and hypoketotic hypoglycemia characteristic of many fatty acid oxidation disorders include the following:</p><ul><li class="half_rhythm"><div>SCAD is only needed at the end of the &#x003b2;-oxidation cycle; therefore, gluconeogenesis and ketogenic capacity from the preceding steps of fatty acid oxidation may be sufficient to meet cellular energy needs [<a class="bk_pop" href="#scad.REF.van_maldegem.2010b.304">van Maldegem et al 2010b</a>].</div></li><li class="half_rhythm"><div>Overlapping substrate specificity by medium-chain acyl CoA dehydrogenase (MCAD) may partially compensate for deficient SCAD activity [<a class="bk_pop" href="#scad.REF.bennett.2010.533">Bennett 2010</a>].</div></li><li class="half_rhythm"><div>While developmental delay and seizures (findings uncommon in other fatty acid oxidation defects) raise the possibility of a neurotoxic effect in SCADD directly related to metabolite accumulation [<a class="bk_pop" href="#scad.REF.gregersen.2001.169">Gregersen et al 2001</a>, <a class="bk_pop" href="#scad.REF.jethva.2008.195">Jethva et al 2008</a>, <a class="bk_pop" href="#scad.REF.van_maldegem.2010c.507">van Maldegem et al 2010c</a>], clinical follow up of individuals identified by <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> argues against any pathogenicity.</div><ul><li class="half_rhythm"><div>Ethylmalonic acid (EMA) inhibits creatine kinase activity, increases lipid peroxidation and protein oxidation, and reduces glutathione levels in the cerebral cortex of Wistar rats [<a class="bk_pop" href="#scad.REF.chen.2003.219">Chen et al 2003</a>, <a class="bk_pop" href="#scad.REF.schuck.2010.298">Schuck et al 2010</a>].</div></li><li class="half_rhythm"><div>EMA inhibits electron transport chain activity in vitro [<a class="bk_pop" href="#scad.REF.barschak.2006.11">Barschak et al 2006</a>].</div></li><li class="half_rhythm"><div>Dicarboxylic acids such as EMA do not cross the blood-brain barrier, and thus sequester in the CNS, another possible explanation of EMA toxicity resulting in neurologic findings [<a class="bk_pop" href="#scad.REF.schuck.2010.298">Schuck et al 2010</a>].</div></li></ul></li><li class="half_rhythm"><div>EMA toxicity may play a role in the neurologic dysfunction observed in ethylmalonic encephalopathy, characterized by psychomotor delays and progressive pyramidal findings resulting from basal ganglia and white matter damage caused by accumulation of large amounts of butyrylcarnitine and EMA [<a class="bk_pop" href="#scad.REF.barth.2010.s443">Barth et al 2010</a>]. However, ethylmalonic encephalopathy is caused by pathogenic variants in <i>ETHE1</i>, the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding a mitochondrial protein involved in scavenging reactive oxygen species (ROS); thus, a direct role for EMA in neurotoxicity is not clear.</div></li><li class="half_rhythm"><div>Butyric acid, which accumulates in SCADD, can modulate <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> expression at high levels as a result of its action as a histone deacetylase [<a class="bk_pop" href="#scad.REF.chen.2003.219">Chen et al 2003</a>]. Its volatile nature may also add to its neurotoxic qualities [<a class="bk_pop" href="#scad.REF.chen.2003.219">Chen et al 2003</a>, <a class="bk_pop" href="#scad.REF.pedersen.2008.43">Pedersen et al 2008</a>, <a class="bk_pop" href="#scad.REF.bennett.2010.533">Bennett 2010</a>].</div></li><li class="half_rhythm"><div>Most pathogenic variants identified in persons diagnosed with SCADD, including the <a class="def" href="/books/n/gene/glossary/def-item/ashkenazi-jewish/">Ashkenazi Jewish</a> <i>ACADS</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK63582/table/scad.T.acads_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figscadTacadsvariantsdiscussedinthis" rid-ob="figobscadTacadsvariantsdiscussedinthis">c.319C&#x0003e;T</a>, are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants that lead to intramitochondrial aggregation of misfolded protein, suggesting that this protein aggregation itself could be cytotoxic [<a class="bk_pop" href="#scad.REF.gregersen.2001.169">Gregersen et al 2001</a>, <a class="bk_pop" href="#scad.REF.pedersen.2008.43">Pedersen et al 2008</a>, <a class="bk_pop" href="#scad.REF.bennett.2010.533">Bennett 2010</a>]. The majority of diseases associated with misfolded proteins exhibit mitochondrial dysmorphology and evidence of increased oxidative stress in cells. In one in vitro study, astrocytes transfected with <i>ACADS</i>
<a class="figpopup" href="/books/NBK63582/table/scad.T.acads_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figscadTacadsvariantsdiscussedinthis" rid-ob="figobscadTacadsvariantsdiscussedinthis">c.319C&#x0003e;T</a> variant accumulated reactive oxygen species (ROS) and demonstrated mitochondrial dysmorphology consistent with a fission defect that could contribute to cellular apoptosis [<a class="bk_pop" href="#scad.REF.schmidt.2010.155">Schmidt et al 2010</a>]. Thus, it is possible that the effect on SCAD protein misfolding could be modulated by genetic background, which in turn would lead to <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a> of disease [<a class="bk_pop" href="#scad.REF.tein.2008.179">Tein et al 2008</a>, <a class="bk_pop" href="#scad.REF.schmidt.2010.155">Schmidt et al 2010</a>].</div></li></ul><p><b>Gene structure.</b>
<i>ACADS</i> is approximately 13 kb long; the transcript <a href="/nuccore/NM_000017.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000017.2</a> comprises ten exons and includes 1,238 nucleotides of coding sequence [<a class="bk_pop" href="#scad.REF.jethva.2008.195">Jethva et al 2008</a>]. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK63582/#scad.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> At least 70 <i>ACADS</i> pathogenic variants, most of which are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, have been reported.</p><p><b>Common (susceptibility) variants.</b> Two <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants have been reported (<a class="figpopup" href="/books/NBK63582/table/scad.T.acads_variants_discussed_in_this/?report=objectonly" target="object" rid-figpopup="figscadTacadsvariantsdiscussedinthis" rid-ob="figobscadTacadsvariantsdiscussedinthis">Table 2</a>) [<a class="bk_pop" href="#scad.REF.van_maldegem.2010c.507">van Maldegem et al 2010c</a>]. Most individuals who are <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for either variant are asymptomatic, although the presence of the variants has been proposed to represent a susceptibility state that requires one or more other genetic factors (e.g., a pathogenic <i>ACADS</i> variant <i>in</i>
<a class="def" href="/books/n/gene/glossary/def-item/trans/"><i>trans</i></a>) or environmental factors to be present for disease to develop [<a class="bk_pop" href="#scad.REF.gregersen.2001.169">Gregersen et al 2001</a>, <a class="bk_pop" href="#scad.REF.van_maldegem.2010c.507">van Maldegem et al 2010c</a>].</p><ul><li class="half_rhythm"><div>c.511C&#x0003e;T in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 5</div></li><li class="half_rhythm"><div>c.625G&#x0003e;A in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 6</div></li></ul><p>Both variants are relatively common in the general population.</p><ul><li class="half_rhythm"><div>In a study of 694 newborns in the United States, approximately 6% were c.625G&#x0003e;A <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a>, 0.3% were c.511C&#x0003e;T homozygous, and 0.9% were <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> (one <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> with each variation) [<a class="bk_pop" href="#scad.REF.van_maldegem.2010c.507">van Maldegem et al 2010c</a>]. This provides an <a class="def" href="/books/n/gene/glossary/def-item/allele-frequency/">allele frequency</a> of 0.22 for the c.625G&#x0003e;A variant and 0.03 for the c.511C&#x0003e;T variant.</div></li><li class="half_rhythm"><div>In the US, 7% of the population is estimated to be either <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> or <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> for one of these common variants [<a class="bk_pop" href="#scad.REF.lindner.2010.521">Lindner et al 2010</a>]. Individuals homozygous for one of the variants have a higher incidence of increased excretion of EMA [<a class="bk_pop" href="#scad.REF.bennett.2010.533">Bennett 2010</a>].</div></li><li class="half_rhythm"><div>In one European study, 14% of controls were <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for one of the variants as compared to 69% of 133 subjects with increased urinary EMA excretion.</div></li></ul><div id="scad.T.acads_variants_discussed_in_this" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>ACADS</i> Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK63582/table/scad.T.acads_variants_discussed_in_this/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__scad.T.acads_variants_discussed_in_this_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_scad.T.acads_variants_discussed_in_this_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant Classification</th><th id="hd_h_scad.T.acads_variants_discussed_in_this_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_scad.T.acads_variants_discussed_in_this_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_scad.T.acads_variants_discussed_in_this_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_scad.T.acads_variants_discussed_in_this_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Pathogenic</b></td><td headers="hd_h_scad.T.acads_variants_discussed_in_this_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.319C&#x0003e;T<br /><a href="/SNP/snp_ref.cgi?rs=61732144" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">rs61732144</a></td><td headers="hd_h_scad.T.acads_variants_discussed_in_this_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg107Cys&#x000a0;<sup>2</sup><br />(Arg83Cys)&#x000a0;<sup>3</sup></td><td headers="hd_h_scad.T.acads_variants_discussed_in_this_1_1_1_4" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_000017.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000017<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/protein/NP_000008.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000008<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_scad.T.acads_variants_discussed_in_this_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Susceptibility variants</b></td><td headers="hd_h_scad.T.acads_variants_discussed_in_this_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.511C&#x0003e;T<br /><a href="/SNP/snp_ref.cgi?rs=1800556" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">rs1800556</a></td><td headers="hd_h_scad.T.acads_variants_discussed_in_this_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg171Trp&#x000a0;<sup>2</sup><br />(Arg147Trp)&#x000a0;<sup>3</sup></td></tr><tr><td headers="hd_h_scad.T.acads_variants_discussed_in_this_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.625G&#x0003e;A<br /><a href="/projects/SNP/snp_ref.cgi?rs=1799958" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">rs1799958</a></td><td headers="hd_h_scad.T.acads_variants_discussed_in_this_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly209Ser&#x000a0;<sup>2</sup><br />(Gly185Ser)&#x000a0;<sup>3</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="scad.TF.2.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd><dt>2. </dt><dd><div id="scad.TF.2.2"><p class="no_margin">Residue in the precursor peptide</p></div></dd><dt>3. </dt><dd><div id="scad.TF.2.3"><p class="no_margin">Residue in the mature enzyme, after cleavage of the 24 N-terminal amino acids of the transit peptide that directs the protein to the mitochondria</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Short-chain-specific acyl-CoA dehydrogenase, mitochondrial (SCAD) like all of the acyl-CoA dehydrogenases (ACAD), is a flavoprotein synthesized in the cytosol as a precursor protein. The precursor protein is transported to the mitochondria and further processed into a mature form via proteolytic cleavage of a mitochondrial targeting (transit) peptide at the amino terminus [<a class="bk_pop" href="#scad.REF.battaile.2002.12200">Battaile et al 2002</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Nearly all individuals identified with SCAD deficiency described to date have pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants that lead to protein misfolding, which has been postulated to cause pathologic cellular effects of SCAD [<a class="bk_pop" href="#scad.REF.schmidt.2010.155">Schmidt et al 2010</a>]. Although the loss of SCAD enzymatic activity clearly leads to the accumulation of abnormal organic acids, no specific clinical syndrome has been substantiated when unbiased patient populations are assessed. Aggregation of abnormally folded SCAD protein in patient cells is distinct and may lead to otherwise unexpected cellular toxicity [<a class="bk_pop" href="#scad.REF.schuck.2010.298">Schuck et al 2010</a>]. Moreover, SCAD misfolding is aggravated by environmental factors that may vary depending on the individual and may interact with currently uncharacterized factors, constituting a possible risk factor for disease [<a class="bk_pop" href="#scad.REF.gregersen.2001.169">Gregersen et al 2001</a>, <a class="bk_pop" href="#scad.REF.pedersen.2008.43">Pedersen et al 2008</a>, <a class="bk_pop" href="#scad.REF.bennett.2010.533">Bennett 2010</a>, <a class="bk_pop" href="#scad.REF.schuck.2010.298">Schuck et al 2010</a>].</p></div></div><div id="scad.References"><h2 id="_scad_References_">References</h2><div id="scad.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="scad.REF.amendt.1987.1303">Amendt BA, Greene C, Sweetman L, Cloherty J, Shih V, Moon A, Teel L, Rhead WJ. Short-chain acyl-coenzyme A dehydrogenase deficiency. Clinical and biochemical studies in two patients. <span><span class="ref-journal">J Clin Invest. </span>1987;<span class="ref-vol">79</span>:1303–9.</span> [<a href="/pmc/articles/PMC424368/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC424368</span></a>] [<a href="/pubmed/3571488" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3571488</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scad.REF.barschak.2006.11">Barschak AG, Ferreira Gda C, Andr&#x000e9; KR, Schuck PF, Viegas CM, Tonin A, Dutra Filho CS, Wyse AT, Wannmacher CM, Vargas CR, Wajner M. Inhibition of the electron transport chain and creatine kinase activity by ethylmalonic acid in human skeletal muscle. <span><span class="ref-journal">Metab Brain Dis. </span>2006;<span class="ref-vol">21</span>:11–9.</span> [<a href="/pubmed/16773466" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16773466</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scad.REF.barth.2010.s443">Barth M, Ottolenghi C, Hubert L, Chr&#x000e9;tien D, Serre V, Gobin S, Romano S, Vassault A, Sefiani A, Ricquier D, Boddaert N, Brivet M, de Keyzer Y, Munnich A, Duran M, Rabier D, Valayannopoulos V, de Lonlay P. Multiple sources of metabolic disturbance in ETHE1-related ethylmalonic encephalopathy. <span><span class="ref-journal">J Inherit Metab Dis. </span>2010;<span class="ref-vol">33</span> Suppl 3:S443–53.</span> [<a href="/pubmed/20978941" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20978941</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scad.REF.battaile.2002.12200">Battaile KP, Molin-Case J, Paschke R, Wang M, Bennett D, Vockley J, Kim JJ. Crystal structure of rat short chain acyl-CoA dehydrogenase complexed with acetoacetyl-CoA: comparison with other acyl-CoA dehydrogenases. <span><span class="ref-journal">J Biol Chem. </span>2002;<span class="ref-vol">277</span>:12200–7.</span> [<a href="/pubmed/11812788" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11812788</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scad.REF.bennett.2010.533">Bennett MJ. Pathophysiology of fatty acid oxidation disorders. <span><span class="ref-journal">J Inherit Metab Dis. </span>2010;<span class="ref-vol">33</span>:533–7.</span> [<a href="/pubmed/20824345" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20824345</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scad.REF.bok.2003.1152">Bok LA, Vreken P, Wijburg FA, Wanders RJ, Gregersen N, Corydon MJ, Waterham HR, Duran M. Short-chain acyl-CoA dehydrogenase deficiency: studies in a large family adding to the complexity of the disorder. <span><span class="ref-journal">Pediatrics. </span>2003;<span class="ref-vol">112</span>:1152–5.</span> [<a href="/pubmed/14595061" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14595061</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scad.REF.chen.2003.219">Chen JS, Faller DV, Spanjaard RA. Short-chain fatty acid inhibitors of histone deacetylases: promising anticancer therapeutics? <span><span class="ref-journal">Curr Cancer Drug Targets. </span>2003;<span class="ref-vol">3</span>:219–36.</span> [<a href="/pubmed/12769690" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12769690</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scad.REF.corydon.2001.18">Corydon MJ, Vockley J, Rinaldo P, Rhead WJ, Kjeldsen M, Winter V, Riggs C, Babovic-Vuksanovic D, Smeitink J, De Jong J, Levy H, Sewell AC, Roe C, Matern D, Dasouki M, Gregersen N. Role of common gene variations in the molecular pathogenesis of short-chain acyl-CoA dehydrogenase deficiency. <span><span class="ref-journal">Pediatr Res. </span>2001;<span class="ref-vol">49</span>:18–23.</span> [<a href="/pubmed/11134486" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11134486</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scad.REF.gallant.2012.55">Gallant NM, Leydiker K, Tang H, Feuchtbaum L, Lorey F, Puckett R, Deignan JL, Neidich J, Dorrani N, Chang E, Barshop BA, Cederbaum SD, Abdenur JE. Biochemical, molecular, and clinical characteristics of children with short-chain acyl-CoA dehydrogenase deficiency detected by newborn screening in California. <span><span class="ref-journal">Mol Genet Metab. </span>2012;<span class="ref-vol">106</span>:55–61.</span> [<a href="/pubmed/22424739" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22424739</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scad.REF.gregersen.2001.169">Gregersen N, Andresen BS, Corydon MJ, Corydon TJ, Olsen RK, Bolund L, Bross P. Mutation analysis in mitochondrial fatty acid oxidation defects: exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship. <span><span class="ref-journal">Hum Mutat. </span>2001;<span class="ref-vol">18</span>:169–89.</span> [<a href="/pubmed/11524729" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11524729</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scad.REF.jethva.2008.195">Jethva R, Bennett MJ, Vockley J. Short-chain acyl-coenzyme A dehydrogenase deficiency. <span><span class="ref-journal">Mol Genet Metab. </span>2008;<span class="ref-vol">95</span>:195–200.</span> [<a href="/pmc/articles/PMC2720545/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2720545</span></a>] [<a href="/pubmed/18977676" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18977676</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scad.REF.lindner.2010.521">Lindner M, Hoffmann GF, Matern D. Newborn screening for disorders of fatty-acid oxidation: experience and recommendations from an expert meeting. <span><span class="ref-journal">J Inherit Metab Dis. </span>2010;<span class="ref-vol">33</span>:521–6.</span> [<a href="/pubmed/20373143" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20373143</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scad.REF.matern.2001.585">Matern D, Hart P, Murtha AP, Vockley J, Gregersen N, Millington DS, Treem WR. Acute fatty liver of pregnancy associated with short-chain acyl-coenzyme A dehydrogenase deficiency. <span><span class="ref-journal">J Pediatr. </span>2001;<span class="ref-vol">138</span>:585–8.</span> [<a href="/pubmed/11295727" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11295727</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scad.REF.nochi.2017.641">Nochi Z, Olsen RKJ, Gregersen N. Short-chain acyl-CoA dehydrogenase deficiency: from gene to cell pathology and possible disease mechanisms. <span><span class="ref-journal">J Inherit Metab Dis. </span>2017;<span class="ref-vol">40</span>:641–55.</span> [<a href="/pubmed/28516284" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28516284</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scad.REF.pedersen.2008.43">Pedersen CB, K&#x000f8;lvraa S, K&#x000f8;lvraa A, Stenbroen V, Kjeldsen M, Ensenauer R, Tein I, Matern D, Rinaldo P, Vianey-Saban C, Ribes A, Lehnert W, Christensen E, Corydon TJ, Andresen BS, Vang S, Bolund L, Vockley J, Bross P, Gregersen N. The ACADS gene variation spectrum in 114 patients with short-chain acyl-CoA dehydrogenase (SCAD) deficiency is dominated by missense variations leading to protein misfolding at the cellular level. <span><span class="ref-journal">Hum Genet. </span>2008;<span class="ref-vol">124</span>:43–56.</span> [<a href="/pubmed/18523805" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18523805</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scad.REF.schmidt.2010.155">Schmidt SP, Corydon TJ, Pedersen CB, Bross P, Gregersen N. Misfolding of short-chain acyl-CoA dehydrogenase leads to mitochondrial fission and oxidative stress. <span><span class="ref-journal">Mol Genet Metab. </span>2010;<span class="ref-vol">100</span>:155–62.</span> [<a href="/pubmed/20371198" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20371198</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scad.REF.schuck.2010.298">Schuck PF, Busanello EN, Moura AP, Tonin AM, Grings M, Ritter L, Vargas CR, da Costa Ferreira G, Wajner M. Promotion of lipid and protein oxidative damage in rat brain by ethylmalonic acid. <span><span class="ref-journal">Neurochem Res. </span>2010;<span class="ref-vol">35</span>:298–305.</span> [<a href="/pubmed/19757035" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19757035</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scad.REF.tein.2008.179">Tein I, Elpeleg O, Ben-Zeev B, Korman SH, Lossos A, Lev D, Lerman-Sagie T, Leshinsky-Silver E, Vockley J, Berry GT, Lamhonwah AM, Matern D, Roe CR, Gregersen N. Short-chain acyl-CoA dehydrogenase gene mutation (c.319C&#x0003e;T) presents with clinical heterogeneity and is candidate founder mutation in individuals of Ashkenazi Jewish origin. <span><span class="ref-journal">Mol Genet Metab. </span>2008;<span class="ref-vol">93</span>:179–89.</span> [<a href="/pubmed/18054510" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18054510</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scad.REF.tonin.2016.114">Tonin R, Caciotti A, Funghini S, Pasquini E, Mooney SD, Cai B, Proncopio E, Donati MA, Baronio F, Bettocchi I, Cassio A, Biasucci G, Bordugo A, la Marca G, Guerrini R, Morrone A. Clinical relevance of short-chain acyl-CoA dehydrogenase (SCAD) deficiency: exploring the role of new variants including the first SCAD-disease-causing allele carrying a synonymous mutation. <span><span class="ref-journal">BBA Clin. </span>2016;<span class="ref-vol">5</span>:114–9.</span> [<a href="/pmc/articles/PMC4816031/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4816031</span></a>] [<a href="/pubmed/27051597" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27051597</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scad.REF.van_maldegem.2006.943">van Maldegem BT, Duran M, Wanders RJA, Niezen-Koning KE, Hogeveen M, Ijlst L, Waterham HR, Wijburg FA. Clinical, biochemical, and genetic heterogeneity in short-chain acyl-coenzyme A dehydrogenase deficiency. <span><span class="ref-journal">JAMA. </span>2006;<span class="ref-vol">296</span>:943–52.</span> [<a href="/pubmed/16926354" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16926354</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scad.REF.van_maldegem.2010a.121">van Maldegem BT, Duran M, Wanders RJ, Waterham HR, de Koning TJ, Rubio E, Wijburg FA. Fasting and fat-loading tests provide pathophysiological insight into short-chain acyl-coenzyme a dehydrogenase deficiency. <span><span class="ref-journal">J Pediatr. </span>2010a;<span class="ref-vol">156</span>:121–7.</span> [<a href="/pubmed/19800078" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19800078</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scad.REF.van_maldegem.2010b.304">van Maldegem BT, Duran M, Wanders RJ, Waterham HR, Wijburg FA. Flavin adenine dinucleotide status and the effects of high-dose riboflavin treatment in short-chain acyl-CoA dehydrogenase deficiency. <span><span class="ref-journal">Pediatr Res. </span>2010b;<span class="ref-vol">67</span>:304–8.</span> [<a href="/pubmed/19952864" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19952864</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scad.REF.van_maldegem.2010c.507">van Maldegem BT, Wanders JA, Wijburg FA. Clinical aspects of short-chain acyl-CoA dehydrogenase deficiency. <span><span class="ref-journal">J Inherit Metab Dis. </span>2010c;<span class="ref-vol">33</span>:507–11.</span> [<a href="/pmc/articles/PMC2946545/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2946545</span></a>] [<a href="/pubmed/20429031" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20429031</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="scad.REF.waisbren.2008.39">Waisbren SE, Levy HL, Noble M, Matern D, Gregersen N, Pasley K, Marsden D. Short-chain acyl-CoA dehydrogenase (SCAD) deficiency: an examination of the medical and neurodevelopmental characteristics of 14 cases identified through newborn screening or clinical symptoms. <span><span class="ref-journal">Mol Genet Metab. </span>2008;<span class="ref-vol">95</span>:39–45.</span> [<a href="/pmc/articles/PMC4204643/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4204643</span></a>] [<a href="/pubmed/18676165" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18676165</span></a>]</div></li></ul></div></div><div id="scad.Chapter_Notes"><h2 id="_scad_Chapter_Notes_">Chapter Notes</h2><div id="scad.Author_Notes"><h3>Author Notes</h3><p>The American College of Medical Genetics has published online an algorithm delineating the appropriate response to an elevated C4 on <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> (<a href="http://www.acmg.net/PDFLibrary/C4.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ACMG-ACT Sheet</a> and <a href="http://www.acmg.net/PDFLibrary/C4-Elevated-Algorithm.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ACMG Algorithm</a> [<a href="https://www.acmg.net/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.acmg.net</a>]).</p></div><div id="scad.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>9 August 2018 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>7 August 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>22 September 2011 (me) Review posted live</div></li><li class="half_rhythm"><div>21 March 2011 (lw) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK63582</span><span class="label">PMID: <a href="/pubmed/21938826" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">21938826</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/spr-def/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/sgs/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK63582&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK63582/?report=reader">PubReader</a></li><li><a href="/books/NBK63582/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK63582" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK63582" style="display:none" title="Cite this Page"><div class="bk_tt">Wolfe L, Jethva R, Oglesbee D, et al. Short-Chain Acyl-CoA Dehydrogenase Deficiency. 2011 Sep 22 [Updated 2018 Aug 9]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK63582/pdf/Bookshelf_NBK63582.pdf">PDF version of this page</a> (445K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#scad.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#scad.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#scad.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#scad.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#scad.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#scad.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#scad.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#scad.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#scad.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#scad.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#scad.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=35[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ACADS</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=2580244" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=2580244" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=2580244" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=2580244" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/16926354" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Clinical, biochemical, and genetic heterogeneity in short-chain acyl-coenzyme A dehydrogenase deficiency.</a><span class="source">[JAMA. 2006]</span><div class="brieflinkpop offscreen_noflow">Clinical, biochemical, and genetic heterogeneity in short-chain acyl-coenzyme A dehydrogenase deficiency.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">van Maldegem BT, Duran M, Wanders RJ, Niezen-Koning KE, Hogeveen M, Ijlst L, Waterham HR, Wijburg FA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">JAMA. 2006 Aug 23; 296(8):943-52. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22424739" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Biochemical, molecular, and clinical characteristics of children with short chain acyl-CoA dehydrogenase deficiency detected by newborn screening in California.</a><span class="source">[Mol Genet Metab. 2012]</span><div class="brieflinkpop offscreen_noflow">Biochemical, molecular, and clinical characteristics of children with short chain acyl-CoA dehydrogenase deficiency detected by newborn screening in California.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gallant NM, Leydiker K, Tang H, Feuchtbaum L, Lorey F, Puckett R, Deignan JL, Neidich J, Dorrani N, Chang E, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Mol Genet Metab. 2012 May; 106(1):55-61. Epub 2012 Feb 9.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29678161" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">An unusually high frequency of SCAD deficiency caused by two pathogenic variants in the ACADS gene and its relationship to the ethnic structure in Slovakia.</a><span class="source">[BMC Med Genet. 2018]</span><div class="brieflinkpop offscreen_noflow">An unusually high frequency of SCAD deficiency caused by two pathogenic variants in the ACADS gene and its relationship to the ethnic structure in Slovakia.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lisyová J, Chandoga J, Jungová P, Repiský M, Knapková M, Machková M, Dluholucký S, Behúlová D, Šaligová J, Potočňáková Ľ, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">BMC Med Genet. 2018 Apr 20; 19(1):64. Epub 2018 Apr 20.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20429031" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Clinical aspects of short-chain acyl-CoA dehydrogenase deficiency.</a><span class="source">[J Inherit Metab Dis. 2010]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Clinical aspects of short-chain acyl-CoA dehydrogenase deficiency.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">van Maldegem BT, Wanders RJ, Wijburg FA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Inherit Metab Dis. 2010 Oct; 33(5):507-11. Epub 2010 Apr 29.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22593918" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Propionic Acidemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Propionic Acidemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Shchelochkov OA, Carrillo N, Venditti C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=21938826" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=21938826" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc8f4375f66d18aa5934ef">Short-Chain Acyl-CoA Dehydrogenase Deficiency - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Short-Chain Acyl-CoA Dehydrogenase Deficiency - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:07:15-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8C88C0DFC886D10000000003530185&amp;ncbi_session=CE8C88C0DFC8F431_0851SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK63582%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK63582&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK63582/&amp;ncbi_pagename=Short-Chain Acyl-CoA Dehydrogenase Deficiency - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C88C0DFC8F431_0851SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>